Patents/Assignees

LIPOZYT MARKER UG

1 patent in portfolio

US12203137utility2025
Use of ADIPOQ Gene Expression Level for Classification of a Subject in Risk Groups in the Prognosis or Diagnosis of Type II Diabetes Mellitus
0 cites